Jahr Robert Charles (CIK 2076177) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy OTLK (151,515 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Outlook Therapeutics, Inc. (OTLK) | Chief Executive Officer | Buy | 151,515 | $0 |
Source: SEC Form 4 filings · as of 2026-08-14